v3.26.3
Income Per Share and Stockholders’ Equity
9 Months Ended
Sep. 30, 2026
Earnings Per Share And Stockholders Equity [Abstract]  
Income Per Share and Stockholders’ Equity 14.        Income Per Share and Stockholders’ Equity
The calculations of basic and diluted income per share attributable to CBRE Group, Inc. stockholders are as follows
(dollars in millions, except share and per share data):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026
2025
2026
2025
Basic Income Per Share
Net income attributable to CBRE Group, Inc. stockholders
$443
$363
$965
$741
Weighted-average shares outstanding for basic income per share
289,273,856
297,557,891
291,788,599
298,589,340
Basic income per share attributable to CBRE Group, Inc. stockholders
$1.53
$1.22
$3.31
$2.48
Diluted Income Per Share
Net income attributable to CBRE Group, Inc. stockholders
$443
$363
$965
$741
Weighted-average shares outstanding for basic income per share
289,273,856
297,557,891
291,788,599
298,589,340
Dilutive effect of contingently issuable shares
2,335,991
2,699,439
2,327,028
2,461,001
Weighted-average shares outstanding for diluted income per share
291,609,847
300,257,330
294,115,627
301,050,341
Diluted income per share attributable to CBRE Group, Inc. stockholders
$1.52
$1.21
$3.28
$2.46
For the three and nine months ended September 30, 2026, 520,253 and 434,264, respectively, of contingently issuable
shares were excluded from the computation of diluted income per share because their inclusion would have had an anti-dilutive
effect.
No shares were excluded from the computation of diluted income per share for the three months ended September 30,
2025. For the nine months ended September 30, 2025, 331,034 of contingently issuable shares were excluded from the
computation of diluted income per share because their inclusion would have had an anti-dilutive effect.
Stock Repurchase Program
On November 21, 2024, our board of directors authorized an additional $5.0 billion to our existing $4.0 billion share
repurchase program (as amended, the 2024 program) bringing the total authorized amount under the 2024 program to a total of
$9.0 billion as of September 30, 2026. The board also extended the term of the 2024 program through December 31, 2029.
During the three months ended September 30, 2026, we repurchased 1,521,085 shares of our common stock with an
average price of $142.74 per share for an aggregate of $217 million under the 2024 program. During the nine months ended
September 30, 2026, we repurchased 8,199,713 shares of our common stock with an average price of $141.77 per share for an
aggregate of $1.2 billion under the 2024 program. As of September 30, 2026, we had approximately $3.7 billion of capacity
remaining under the 2024 program.
We did not repurchase any shares of our common stock during the three months ended September 30, 2025 under the
2024 program. During the nine months ended September 30, 2025, we repurchased 5,185,163 shares of our common stock with
an average price of $127.82 per share for an aggregate of $663 million under the 2024 program.